Blog Archives

exposure to anticholinergic drugs increases risk of dementia

7/11/2019

Scientists reported that exposure to anticholinergic drugs such as antidepressants (for example, paroxetine or amitriptyline), bladder antimuscarinics (for example, oxybutynin or tolterodine), antipsychotics (for example, chlorpromazine or olanzapine) and antiepileptic drugs (for example, oxcarbazepine or carbamazepine) increase the risk of dementia by about 50%. Read the full report here.

Anticholinergic drugs linked to higher risk of dementia

0 Comments

The information on this website, true and complete to the best of our knowledge, is intended as an informative guide only. The information on this website is offered with no guarantees on the part of the authors and the authors disclaim all liability in connection with the use of this information. This information is not intended as a substitute for the medical advice of your own physician(s) nor is it intended to replace, conflict or countermand with the advice of your physician(s). The reader should regularly consult a physician in matters relating to his or her health and particularly with respect to any symptoms that may require diagnosis or medical attention. The ultimate decision concerning your care should be made between you and your physician(s). We strongly recommend you follow his or her advice.

Author

Dr. Ayati is a well-known, nationally and internationally, geriatrician, speaker, author, and an educator.

exposure to anticholinergic drugs increases risk of dementia

Author

Archives

Categories